David M. Labiner, MD

Department of Neurology - Faculty

David Labiner, MD David M. Labiner, MD
Department Head, Department of Neurology
Professor of Neurology
Director, Arizona Comprehensive Epilepsy Program


Education/Training:

BS: Emory University, 1979
MD: Medical College of Georgia, 1984
Internship: Medical College of Georgia, 1984-85
Residency: Neurological Institute of New York / Columbia-Presbyterian Medical Center, 1985-88
Fellowship (Epilepsy): Duke Center for the Advanced Study of Epilepsy, 1988-89
Board Certification: Neurology, American Board of Psychiatry and Neurology

Clinical/Research Interests: Epilepsy; Electroencephalograpy; Pharmacology of Seizure Generation and Control; Epidemiology of Epilepsy

Publications:

Articles:

  • Smith DB, Sidman RD, Henke JS, Flanigin HF, Labiner DM, Evans CN. Scalp and depth recordings of induced deep cerebral potentials. Electroencephalography and Clinical Neurophysiology 55: 145 150, 1983.
  • Smith DB, Sidman RD, Flanigin HF, Henke JS, Labiner DM. A reliable method for localizing deep intracranial sources of the EEG. Neurology 35: 1702 1707, 1985.
  • Simonato MG, Hosford DA, Labiner DM, Shin C, Mansbach HH, McNamara JO. Differential expression of immediate early genes in the hippocampus in the kindling model of epilepsy. Molecular Brain Research 11: 115-124, 1991.
  • Sorock GS, Labiner DM. Peripheral neuromuscular dysfunction and the risk of falling in the elderly. American Journal of Epidemiology 136: 584-591, 1992.
  • Labiner DM, Butler LS, Cao Z, Hosford DA, Shin C, McNamara JO. Induction of c-fos mRNA by kindled seizures: Lack of correlation with neuronal burst firing. The Journal of Neuroscience 13: 744-751, 1993.
  • Ahern GL, Herring AM, Tackenberg J, Seeger JF, Oommen KJ, Labiner DM, Weinand ME. The association of multiple personality and temporolimbic epilepsy: Intracarotid amobarbital test observations. Archives of Neurology 50: 1020-1025, 1993.
  • Ahern GL, Herring AM, Tackenberg JN, Schwartz GE, Seeger JF, Labiner DM, Weinand ME, Oommen KJ. Affective self-report during the intracarotid sodium amobarbital test. Journal of Experimental and Clinical Neuropsychology 16: 372-376, 1994.
  • Weinand ME, Hermann BP, Wyler AR, Carter LP, Oommen KJ, Labiner DM, Ahern GL, Herring AM. Long-term subdural strip electrocorticographic monitoring of ictal déjà vu. Epilepsia 35: 1054-1059, 1994.
  • Lleu PL, Labiner DM, Weinand ME, Huxtable RJ. Neuroactive amino acids in synaptosomes from focal and nonfocal temporal lobe tissue of patients with intractable complex partial seizures. Advances in Experimental Medicine and Biology 359: 435-444, 1994.
  • Ahern GL, Labiner DM, Hutzler R, Osburn C, Talwar D, Herring AM, Tackenberg JN, Oommen KJ, Weinand ME. Quantitative analysis of the EEG in the intracarotid amobarbital test: I. Amplitude analysis. Electroencephalography and Clinical Neurophysiology 91: 21-32, 1994.
  • Weinand ME, Carter LP, Patton DD, Oommen KJ, Labiner DM, Talwar D. Long-term surface cortical cerebral blood flow monitoring in temporal lobe epilepsy. Neurosurgery 35: 664, 1994.
  • Ahern GL, Labiner DM, Talwar D, Herring AM, Tackenberg J, Weinand ME, Oommen KJ. Quantitative analysis of the EEG in the intracarotid amobarbital test: II. Coherence analysis. Journal of Clinical Neurophysiology 12: 285-290, 1995.
  • Weinand ME, El-Saadany WF, Carter LP, Labiner DM, Oommen KJ, Talwar D, Ahern GL. Temporal lobe ischemia and epileptogenicity: Long-term cortical cerebral blood flow analysis of sequential seizures. Surgical Forum 46: 574-575, 1995.
  • Weinand ME, Carter LP, Oommen KJ, Hutzler R, Labiner DM, Talwar D, El-Saadany WF, Ahern GL. Response of human epileptic temporal lobe cortical blood flow to hyperventilation. Epilepsy Research 21: 221-226, 1995.
  • Devinsky O and the Intravenous Valproate Study Team. Safety of intravenous valproate. Annals of Neurology 38: 670-674, 1995.
  • Weinand ME, El-Saadany W, Labiner DM, Talwar D, Ahern G. Subdural strip electrode monitoring and surgical decision making in refractory epilepsy: Validity and prognositic value of noninvasive localizing data. Journal of Epilepsy 8: 131-138, 1995.
  • Labiner DM. Vagal nerve stimulation - A new paradigm for treating epilepsy. Clinical Research News for Arizona Physicians 7: 1, 1996.
  • Labiner DM. New anti-epileptic medications: new hope for individuals with seizures. Clinical Research News for Arizona Physicians 7: 2, 1996.
  • Weinand ME, El-Saadany W, Labiner DM, Carter LP, Oommen KJ, Talwar D, Ahern G. Abnormal vasomotor response of human epileptogenic cortex to reversal of hyperventilation: A long-term surface cerebral blood flow monitoring study. Pathophysiology 3: 41-45, 1996.
  • Weinand ME, Carter LP, El-Saadany WF, Sioutos PJ, Labiner DM, Oommen KJ. Cerebral blood flow and temporal lobe epileptogenicity. Neurosurgical Focus, "Epilepsy", November, 1996 (NEUROSURGERY://ON-CALL web site at http://www.aans.org).
  • Weinand ME, Carter LP, El-Saadany WF, Sioutos PJ, Labiner DM, Oommen KJ. Cerebral blood flow and temporal lobe epileptogenicity. Journal of Neurosurgery 86: 226-232, 1997.
  • Ahern GL, Herring AM, Labiner DM, Weinand ME. Quantitative analysis of hemispatial neglect in the intracarotid sodium amobarbital test. Journal of the International Neuropsychological Society 4: 99-105, 1998.
  • Semenchuk MR, Labiner DM. Gabapentin and Lamotrigine: Guidelines for psychiatry. Journal of Practical Psychiatry and Behavioral Health 3: 334-342, 1997.
  • Grudzinski AN, Hakim Z, Coons SJ, Labiner DM. An assessment of the usefulness of the QOLIE-31 in routine clinical practice. Journal of Epilepsy 11: 34 - 47, 1998.
  • Handforth A, and the E05 Study Team. Vagus nerve stimulation therapy for partial onset seizures. Neurology 51: 48-55, 1998.
  • Zahn CA, Morrell MJ, Collins SD, Labiner DM, Yerby MS. Management issues for women with epilepsy: A review of the literature. Neurology 51: 949-956, 1998.
  • Griffiths RI, Schrammel PN, Morris GL, Wills SH, Labiner DM, Strauss MJ. Payer costs of patients diagnosed with epilepsy. Epilepsia 40: 351-358, 1999.
  • Zahn CA, Morrell MJ, Collins SD, Labiner DM, Yerby MS. Management issues for women with epilepsy. (Correspondence). Neurology 53: 656, 1999.
  • Murphy JV and the Pediatric VNS Study Group. Left vagal nerve stimulation: Experience in 60 children with pharmacoresistant epilepsy. Journal of Pediatrics 134: 563-566, 1999.
  • Labiner DM. Data v. opinion, phenytoin versus fosphenytoin: The saga continues. Archives of Internal Medicine 159: 2631-2632, 1999.
  • Weinand ME, Takacs I, Ahern GL, Labiner DM. Nonepileptic cortical cerebral blood flow and temporal lobe epileptogenicity. Pathophysiology 6: 135-141, 1999.
  • Morris GL III and the Vagus Nerve Stimulation Study Group. Long-term treatment with vagus nerve stimulation in refractory epilepsy patients. Neurology 53: 1731-1735, 1999.
  • Labiner DM, Yan CC, Weinand ME, Huxtable RJ. Disturbances of amino acids from temporal lobe synaptosomes in human complex partial epilepsy. Neurochemical Research 24: 1379-1383, 1999.
  • Rapcsak SZ, Galper SR, Comer JF, Reminger MA, Nielsen L, Kaszniak AW, Verfaellie M, Laguna JF, Labiner DM, Cohen RA. The perception of fear: a cautionary note. Neurology 54: 575-581, 2000.
  • Sirven JI and the Vagus Nerve Stimulation Study Group. Vagus nerve stimulation therapy for epilepsy in older adults. Neurology 54: 1179-1182, 2000.
  • Grudzinski AN, Hakim Z, Labiner DM, Cox ER, Bootman JL. An economic assessment of the relationship between disease exacerbations and the cost of multiple sclerosis to a managed care organization. Journal of Managed Care Pharmacy 6: 19-24, 2000.
  • Ahern GL, Herring AM, Weinand ME, Hutzler R, Labiner DM. Affective self-report during the ISA: Group differences. Journal of International Neuropsychological Society 6: 659-667, 2000.
  • Weinand ME, Deogaonkar M, Kester M, Ahern GL, Labiner DM. Electrographic factors associated with temporal lobe epileptogenicity. Pathophysiology 7: 33-39, 2000.
  • DeGiorgio CM and VNS Study Group. Prospective long-term study of vagus nerve stimulation for the treatment of refractory partial seizures. Epilepsia 41: 1195-1200, 2000.
  • Dasheiff RM and VNS Study Group. Vagal nerve stimulation does not unkindle seizures. Journal of Clinical Neurophysiology 18: 68-74, 2001.
  • Ahern GL, Sollers J, Lane RD, Labiner DM, Herring AM, Weinand ME, Hutzler R, Thayer J.  Heart rate and heart rate variability changes in the intracarotid sodium amobarbital (ISA) test.  Epilepsia 42: 912-921, 2001.
  • Weinand ME, Labiner DM, Ahern GL. Temporal lobe seizure interhemispheric propagation time depends on nonepileptic cortical cerebral blood flow. Epilepsy Research 44: 33-39, 2001.
  • Weinand ME, Kester MM, Labiner DM, Ahern GL. Time from ictal subdural EEG seizure onset to clinical seizure onset: Prognostic value for selecting temporal lobectomy candidates. Neurological Research 23: 599-604, 2001.
  • Walczak TS and the Committee to Revise the Guidelines for Specialized Epilepsy Centers. Guidelines for essential services, personnel, and facilities in specialized epilepsy centers. Epilepsia 42: 804-814, 2001.
  • Skaff PT, Labiner DM. Status epilepticus due to human parvovirus B19 encephalitis in an immunocompetent adult. Neurology 57: 1336-1337, 2001.
  • Weinand ME, Labiner DM, Ahern GL. Integration of perceptual and mnemonic dysfunction: Sensory auras are associated with left hemisphere memory dysfunction. Epilepsy and Behavior 2: 423-432, 2001.
  • Labiner DM and Ahern GL. Neurologic consultation for seizures: When, why and how to pursue. Postgraduate Medicine 111:53-64, 2002.
  • Labiner DM. The Centers for Disease Control and Prevention and its epilepsy initiative. The Ictal Zone 4: 2 (Newsletter of the AAN Epilepsy Section), 2002.
  • Labiner DM. Alternative medicine and the treatment of epilepsy (letter). Epilepsy and Behavior 3: 200-201, 2002.
  • Labiner DM. An evaluation of SPD-421 (DP-VPA) in the treatment of epilepsy. Current Opinion in Investigational Drugs 3: 921 - 923, 2002.
  • Labiner DM. Lamotrigine and rash: scratching beneath the surface. Journal of Clinical Psychiatry 63: 1010, 2002.
  • Labiner DM, Weinand ME, Ahern GL, Herring AM. Prognostic value of concordant seizure focus localizing data in the selection of temporal lobectomy candidates. Neurological Research 24: 747 - 755, 2002.
  • Labiner DM. Treating refractory disease. In, Labiner DM, Benbadis SR, Wilner AA. Current management of epilepsy. The Virtual Lecture Hall (On-line CME). http://www.vlh.com. 2003
  • Drazkowski JF, Fisher RS, Sirven JI, Uber-Zak L, Hentz J, Labiner DM. Seizure related crashes in Arizona before and after shortening the driving restriction from 12 to 3 months. Mayo Clinic Proceedings 78: 819 - 825, 2003.
  • Skaff PT, Labiner DM. Human parvovirus B19: a rare cause of adult encephalitis and status epilepticus. Infectious Diseases: review series 3: 14 - 16, 2003.
  • Labiner DM. Neuronal substrates of sleep and epilepsy. (Book review). Sleep 27: 2004.
  • Gonzalez-Portillo G, Rivero S, Ahern GL, Labiner DM, Weinand ME. Normalization of periictal bihemispheric cerebral perfusion in temporal lobe epilepsy. Pathophysiology 11: 31 - 34, 2004.
  • Reminger SL, Kaszniak AW, Labiner DM, Littrell LD, David BT, Ryan L, Herring AM, Kaemingk KL. Bilateral hippocampal volume predicts verbal memory function in temporal lobe epilepsy. Epilepsy and Behavior 5: 687-695, 2004.
  • Labiner DM. Treating refractory disease. Current management of epilepsy: Primary Care Edition. The Virtual Lecture Hall (On-line CME). http://www.vlh.com. 2004
  • Carpenter LL, Moreno FA, Kling MA, Anderson GM, Regenold WT, Labiner DM, Price LH. Effect of vagus nerve stimulation on CSF monoamine metabolites, norepinephrine, and GABA concentrations in depressed patients. Biological Psychiatry, in press, 2004.

Book Chapters:

  • Labiner DM, contributing author. In Schachter SC and Rowan J, The Brainstorms Healer. Epilepsy in Our Experience. Philadelphia: Lippincott-Raven Publishers, 1998.
  • Labiner DM, Kunkel-Thomas J, Anderson LR. Neurology in Native Americans. In Galloway JM, Goldberg BW, Alpert JA (eds.), Clinical Medicine for Native Americans: Epidemiology, Pathology, Diagnosis and Therapy. Boston: Butterworth Heinemann, 1999.
  • Labiner DM. Status epilepticus after a long day of white-water rafting in the Grand Canyon. In Schmidt D and Schachter S (eds.), 110 Cases of Epilepsy, London: Martin Dunitz Publishers Ltd., 2001.
  • Armstrong EP, Labiner DM. Epilepsy. In Katz MD and Bressler R (eds.), Geriatric Pharmacology, 2nd ed., in press, 2003.

Abstracts:

  • Smith DB, Sidman RD, Henke JS, Weitz F, Kearfott B, Labiner DM. Detection of focal cortical dysfunction using the visual evoked response. Presented at the Second Annual International Evoked Potential Symposium, 18 - 20 October 1982, Cleveland, Ohio
  • Smith DB, Sidman RD, Henke JS, Flanigin HF, Evans CN, Labiner DM. Validation of a computer method for localizing EEG potentials. Presented at the Southern EEG Society Meeting, 29-31 October 1982, Williamsburg, Virginia
  • Smith DB, Sidman RD, Henke JS, Flanigin HF, Evans CN, Labiner DM. A reliable method for localizing both depth and superficially generated EEG potentials. Neurology 33 (Suppl 2): 70, 1983
  • Smith DB, Henke JS, Sidman RD, Flanigin HF, Labiner DM. Validation of a noninvasive method for localizing intracranial sources of EEG. Neurology 34 (Suppl 1): 124, 1984
  • Ng SKC, Labiner DM, Hauser WA, Brust JCM, Healton EB. Neurological deficits and adult-onset seizures. Neurology 37 (Suppl 1): 323, 1987
  • Labiner DM, Ng SKC, Hauser WA, Brust JCM. Cerebellar dysfunction increases risk for seizures. Epilepsia 28: 634, 1987
  • Sorock GS, Labiner DM, Hauser WA. Peripheral nerve dysfunction and the risk of falls in the elderly. American Journal of Epidemiology 130: 817-818, 1989
  • Labiner DM, Hosford DA, Shin C, McNamara JO. N-methyl-D-aspartate channel blockers inhibit seizure induced rise in c-fos mRNA in hippocampus of kindled rats. Society of Neuroscience Abstracts 15 (1): 841, 1989
  • Simonato MG, Hosford DA, Labiner DM, Shin C, McNamara JO. Early gene expression in the hippocampus in the kindling model. Society of Neuroscience Abstracts 15 (1): 841, 1989
  • Labiner DM, Hosford DA, Shin C, McNamara JO. An N-methyl-D-aspartate channel blocker, MK-801, inhibits seizure induced rise in c-fos mRNA in hippocampus of kindled rats. Epilepsia 30: 697, 1989
  • Shin C, Labiner DM, Hosford DA, McNamara JO. N-methyl-D-aspartate (NMDA) receptor activation is required for full expression of c-fos mRNA induced by kindled seizures. Neurology 40 (Suppl 1): 211, 1990
  • Labiner DM, Hosford DA, Shin C, Cao Z, Butler L, McNamara JO. Dissociation of neuronal activity and seizure-induced c-fos mRNA expression by NMDA receptor antagonist. Society of Neuroscience Abstracts 16 (1): 848, 1990
  • Oommen KJ, Patton D, Fenstermacher W, Seeger J, Carter LP, Weinand ME, Labiner DM, Ahern G, Herring A, Tackenberg J, Martynec C. Comparison of SPECT and MRI foci to EEG foci in patients with complex partial seizures. Neurology 42 (Suppl 3): 157, 1992
  • Weinand ME, Carter LP, Oommen KJ, Labiner DM, Patton D, Orozco J, Ahern G, Herring A. Surface monitoring of cerebral cortical blood flow in epilepsy. Neurology 42 (Suppl 3): 158, 1992
  • Labiner DM, Weinand ME, Ahern GL, Oommen KJ, Carter LP, Patton D, Herring A. Concordance between noninvasive and invasive evaluation techniques in seizure focus localization. Epilepsia 33 (Suppl 3): 91, 1992
  • Weinand ME, Wyler AR, Carter LP, Oommen KJ, Labiner DM, Ahern GL, Hermann B, Herring A. Long-term subdural strip electrocorticographic monitoring of ictal deja vu. Epilepsia 33 (Suppl 3): 95, 1992
  • Huxtable RJ, Lieu PL, Weinand ME, Labiner DM. Decreased synaptosomal taurine and glutamine concentrations in focal as compared to nonfocal temporal lobe tissue biopsied from patients with intractable complex partial seizures. Presented at the International Symposium on Taurine in Health and Disease, 29 August - 1 September 1993, Cologne, Germany
  • Labiner DM, Lieu PL, Weinand ME, Huxtable RJ. Neuroactive amino acids in synaptosomes from focal and nonfocal temporal lobe tissue biopsied from patients with intractable complex partial seizures. Society of Neuroscience Abstracts 16 (2): 1028, 1993
  • Sachdeo RC and the M91-605 Investigators. Safety and efficacy of bid and qid dosing with tiagabine HCl versus placebo as adjunctive treatment for partial seizures. Epilepsia 34 (Suppl 6): 36, 1993
  • Hutzler R, Oommen KJ, Ahern GL, Weinand ME, Carter LP, Labiner DM, Talwar D. Cerebral blood flow during hyperventilation in epileptic and nonepileptic temporal cortex. Epilepsia 34 (Suppl 6): 77, 1993
  • Weinand ME, Carter LP, Oommen KJ, Labiner DM, Talwar D, Orozco JA. Long-term surface cortical cerebral blood flow monitoring in temporal lobe epilepsy. Epilepsia 34 (Suppl 6): 97, 1993
  • Labiner DM, Lieu PL, Weinand ME, Huxtable RJ. Alterations in neuroactive amino acids in synaptosomes isolated from both focal and nonfocal temporal lobe of individuals with medically intractable epilepsy. Epilepsia 34 (Suppl 6): 126, 1993
  • Ahern GL, Herring AM, Tackenberg JN, Schwartz GE, Seeger JF, Labiner DM, Weinand ME, Oommen KJ. Affective self-report during the intracarotid sodium amobarbital test. Presented at the International Neuropsychological Society Meeting, 2-5 February 1994, Cincinnati, Ohio
  • Labiner DM, Ahern GL, Kolb MA, Johnson DS, Vengrow MI. Gabapentin is both safe and effective in treating seizures associated with porphyria. Epilepsia 35 (Suppl 8): 53, 1994
  • Talwar D, Weinand ME, Baldwin MA, Labiner DM, Griesemer DA, Oommen KJ. Surgical treatment of intractable symptomatic occipital epilepsy. Epilepsia 35 (Suppl 8): 69, 1994
  • Weinand ME, Labiner DM, Oommen KJ, Talwar D. Subdural strip monitoring and surgical decision making in refractory epilepsy. Epilepsia 35 (Suppl 8): 71, 1994
  • Weinand ME, Carter LP, Oommen KJ, Hutzler R, Labiner DM, Talwar D, El-Saadany WF, Ahern GL. Response of human epileptic temporal lobe cortical blood flow to hyperventilation. Epilepsia 36 (Suppl 4): 141, 1995
  • Labiner DM, McGregor T, Ahern GL, Bell S. The cost of epilepsy in Yuma County, Arizona. Epilepsia 36 (Suppl 4): 95, 1995
  • Weinand ME, El-Saadany WF, Labiner DM, Talwar D, Ahern GL. Subdural strip electrode monitoring and surgical decision making in refractory epilepsy: Validity and prognositic value of noninvasive localizing data. Presented at the 41st Annual Meeting of the Western Neurosurgical Society, Gleneden Beach, Oregon, 9 - 12 September 1995.
  • Weinand ME, El-Saadany WF, Sioutos PJ, Carter LP, Labiner DM, Oommen KJ. Vascular steal theory of epileptogenicity. Presented at the 46th Annual Meeting of Congress of Neurological Surgeons, Montreal, Quebec, Canada, 28 September - 3 October 1996
  • Weinand ME, Carter LP, El-Saadany WF, Sioutos PJ, Labiner DM, Oommen KJ. Cerebral blood flow and temporal lobe epileptogenicity. Epilepsia 37 (Suppl 4): 89, 1996
  • Ahern GL, Herring AM, Labiner DM, Weinand ME. Quantification of hemispatial neglect during the intracarotid amytal procedure. Presented at the 25th Annual Meeting, International Neuropsychological Society, Orlando, Florida, 5-8 February 1997
  • Labiner DM, McGregor T, Ahern GL, Bell S. The cost of epilepsy in Yuma County, Arizona. Epilepsia 38 (Suppl 3): 95, 1997
  • Labiner DM, Yan CC, Weinand ME, Huxtable RJ. Disturbances of amino acids from temporal lobe synaptosomes in human complex partial epilepsy. Presented at the International Taurine Symposium, Tucson, Arizona, 15 - 19 July 1997
  • Labiner DM. Results from long-term safety and efficacy monitoring. Presented at the North American Vagus Nerve Stimulation Symposium, Colorado Springs, Colorado, 17 - 20 August 1997
  • Labiner DM, Ahern GL. A meta-analysis of vagus nerve stimulation in treating medically refractory epilepsy. Epilepsia 38 (Suppl 8): 109, 1997
  • DeGiorgio C et al. Multicenter, double-blind controlled trial of vagus nerve stimulation (NCP system) for medically intractable partial-onset seizures: initial report of the United States E05 study group. Epilepsia 38 (Suppl 8): 133, 1997
  • Reminger SL, Herring AM, Ahern GL, Weinand ME, Labiner DM. The utility of neuropsychological test measures in the prediction of seizure lateralization in temporal lobe epilepsy. Presented at the 26th Annual International Neuropsychological Society, Honolulu, Hawaii, February 1998
  • Griffiths RI, Schrammel PN, Morris GL, Wills SH, Labiner DM, Strauss MJ. Payor costs of patients diagnosed with epilepsy. Epilepsia 39 (Suppl 6): 225, 1998.
  • DeGiorgio CM and the E05 Study Group. Multicenter double-blind crossover and 6-month follow-up study of vagus nerve stimulation for intractable partial seizures. Epilepsia 39 (Suppl 6): 69, 1998.
  • Sirven JI and the VNS Study Group. Vagus nerve stimulation therapy for epilepsy in adults 50 years and older: A multicenter study. Neurology 52 (Suppl 2): A110, 1999.
  • DeGiorgio C and the VNS Study Group. Multicenter long-term efficacy and safety study of vagus nerve stimulation for intractable partial seizures. Neurology 52 (Suppl 2): A111, 1999.
  • Morris GL and the VNS Study Group. Seizure freedom analysis on 195 refractory epilepsy patients receiving vagus nerve stimulation therapy. Neurology 52 (Suppl 2): A239, 1999.
  • Weinand ME, Deogaonkar M, Kester M, Labiner DM. Time from electrocorticographic to -clinical seizure onset: Prognostic value for selecting temporal lobectomy candidates. Epilepsia 40 (Suppl 2): 29, 1999.
  • Deogaonkar M, Weinand ME, Labiner DM. Non-invasive versus invasive focus localization in surgical decision making in epilepsy surgery. Epilepsia 40 (Suppl 2): 83, 1999.
  • Deogaonkar M, Weinand ME, Labiner DM. Role of invasive monitoring in surgical decision making in epilepsy surgery. Neurosurgery 45: 699, 1999.
  • Drazkowski JF, Fisher RS, Blum DE, Labiner DM. Driving crashes in Arizona after reducing the required seizure-free interval. Epilepsia 40 (Suppl 7): 104, 1999.
  • Labiner DM, Schwirtz D, Ahern G, MacDonald J, Weinand ME. Shorter pulse width of vagus nerve stimulation is as effective in reducing seizure frequency as standard stimulation and is better tolerated. Epilepsia 40 (Suppl 7): 141, 1999.
  • Cantrell D and the Depakote Study Team. Rapid infusions of valproate sodium injection (Depacon) are safe and well tolerated. Presented at the American Epilepsy Society Annual Meeting, Los Angeles, California, December 1-6, 2000.